|
|
DAVITA INC : Falcon EHR Receives 'Meaningful Use' Certification - 4-traders (press release) |
4-traders (press release)
The interconnectivity promoted by Falcon EHR, including integration with DaVita's dialysis center systems, laboratory system as well as other industry laboratory and practice management applications, is designed to connect physicians across points of
|
|
|
Pfizer asks EU to approve kidney cancer drug - BusinessWeek |
BusinessWeek
Pfizer wants approval to market axitinib as a treatment for advanced renal cell carcinoma in patients who haven't been helped by other therapies. Axitinib is taken by mouth and is designed to block receptors that influence tumor growth, blood vessel ...
Pfizer Files For European Regulatory Review Of Axitinib For Patients With
|
|
Aethlon Medical President Rodney S. Kenley to Present at the 20th ... - PR Newswire (press release) |
PR Newswire (press release)
The Aethlon Hemopurifier® is a first-in-class therapeutic filtration device that selectively removes infectious viruses and immunosuppressive toxins from the entire circulatory system through the use of dialysis machines and other blood circulatory
|
|
Research and Markets: Hungary Nephrology and Urology Devices Investment ... - TMC Net |
TMC Net
Hungary Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2017, a new report by Global Markets Direct, provides key market data on the Hungary Nephrology and Urology Devices market. The report provides value (USD
|
|
Final Analysis From AVEO Pharmaceuticals' Phase 2 Trial Of Tivozanib In ... - TheStreet.com (press release) |
TheStreet.com (press release)
... analysis of its Phase 2 randomized discontinuation trial evaluating tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with advanced renal cell carcinoma (RCC).
|
|
|
|
|
<< Start < Prev 871 872 873 874 875 876 877 878 879 880 Next > End >>
|
|
Page 876 of 2630 |